Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Especially valuable for young patients with multiple blocks & underlying conditions that may render angioplasty procedures with drug-eluting stents ineffective
With close to 30-40 basic screening tests available, the unit encompasses all the essential parameters typically covered in annual health check-ups
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
Effective disaster response and management is a collaborative work
The EU certification will support supplies of drug products registered in Europe, from this manufacturing site
US formulations revenue increased by 11.6% YoY to Rs. 3,045 crore and Europe formulation revenue stood at Rs. 1,660 crore
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
MoU signed between AIIA and University of Amrita Vishwa Vidhyapeetham for collaboration in the field of Research and Academics in Ayurveda
Subscribe To Our Newsletter & Stay Updated
